Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 21, 2018

DHA signs new partnerships to accelerate healthcare innovations

The Dubai Health Authority (DHA) has signed four new memorandums of understanding (MoU) to bolster its medical system and deliver improved health care services through new medical technologies in artificial intelligence (AI) for diagnosis and treatment.

The Dubai Health Authority (DHA) has signed four new memorandums of understanding (MoU) to bolster its medical system and deliver improved health care services through new medical technologies in artificial intelligence (AI) for diagnosis and treatment.

One of the new deals is for Babylon’s health app which employs AI to allow all-time video consultations with doctors in North America, Europe, Asia and Africa.

The consultations are offered through an AI chatbox and a live question-and-answer session with the user. The app suggests an appropriate doctor for the user based on the symptoms and other pieces of information shared by the patient during the chat.

“DHA director general Humaid Al Qutami said that the authority aims to create an integrated global platform to generate economic value and support future businesses and technological solutions.”

Set to be available in Dubai over the coming months, the app has been upgraded with the cultural requirements of the region.

DHA also partnered with Health Care and Innovative New Technology (HiNT) on a neuro headband developed to identify a stroke within minutes.

The device is designed to notify the caregiver and the emergency services in minutes to avoid deterioration of the patient.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

The authority is also bringing AI-assisted Bodyo health pods that are designed as a cubicle where people can undergo free of cost screening for vital signs such as body temperature, blood sugar and pressure, and body composition.

These pods are intended to offer an idea of the user’s health, facilitating preventive health check-up.

The MoU with Admetsys covers flow cell sensors, which employ an algorithm to continuously measure vitals in ICU patients. The sensors detect any sudden drop in vitals.

DHA director general Humaid Al Qutami said that the authority aims to create an integrated global platform to generate economic value and support future businesses and technological solutions.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU